A vs ACTU: Which Stock is Better?
Side-by-side comparison of Agilent Technologies Inc and Actuate Therapeutics Inc in 2026
A
Agilent Technologies Inc
$117.50
ACTU
Actuate Therapeutics Inc
$1.82
Key Metrics Comparison
| Metric | A | ACTU | Winner |
|---|---|---|---|
| Market Cap | $32.54B | $40.78M | A |
| P/E Ratio | 25.40 | N/A | A |
| EPS (TTM) | $4.53 | $N/A | A |
| Revenue Growth | 0.1% | 0.0% | A |
| Gross Margin | 52.3% | 0.0% | A |
Analyze A
Full quant analysis
Analyze ACTU
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is A or ACTU a better investment?
Comparing A and ACTU: Agilent Technologies Inc has a market cap of $32.54B while Actuate Therapeutics Inc has $40.78M. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between A and ACTU?
A (Agilent Technologies Inc) and ACTU (Actuate Therapeutics Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: A or ACTU?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: A or ACTU?
A has higher revenue growth at 0.1% vs 0.0% for ACTU.
Which company is more profitable: A or ACTU?
Agilent Technologies Inc (A) has higher gross margins at 52.3% compared to 0.0% for ACTU.
Which is the larger company: A or ACTU?
Agilent Technologies Inc (A) is larger with a market cap of $32.54B compared to $40.78M for ACTU.
Should I buy A or ACTU in 2026?
Both A and ACTU have investment merit. A trades at $117.50 while ACTU trades at $1.82. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between A and ACTU stock?
Key differences: Market Cap ($32.54B vs $40.78M), P/E Ratio (25.4x vs N/A), Revenue Growth (0.1% vs 0.0%), Gross Margin (52.3% vs 0.0%).